Item
L-Carnitine (6300)
L-CARNITINE- 100%
Nutrient / Vitamin
Attributes
- Gluten-free
- Halal
- Ingredient declaration
- Kosher
- PHO-free
- Vegan
- Non-GMO
Locations
Location name | Address |
---|---|
CHENGDA PHARMACEUTICALS CO LTD | No. 36, Huanghe Road, Huimin Subdistrict, Jiashan Jiaxing, ZJ 314100 CHN |
Kaiyuan Hengtai Nutrition Co., Ltd. | No.18, Yihe Road Kaiyuan City, Liaoning Province xxx CHN |
Northeast Pharmaceutical Group Co., Ltd. No.29 | No. 29 Shenxiliu Dong Road Economic Technological Development District, Shenyang xxx CHN |
Northeast Pharmaceutical Group Co., Ltd. No.37 | No. 37, Zhonggong Bei Street Tiexi District, Shenyang, Liaoning Province xxx CHN |
Prinova USA | 6525 Muirfield Drive. Hanover Park, IL 60133 |
Documents
Type | Location | File name | Effective | Expiration |
---|---|---|---|---|
HACCP | CHENGDA PHARMACEUTICALS CO LTD | 3rd party-Haccp doc - Prinova.pdf | 6/20/2019 | 6/19/2022 |
HACCP | Kaiyuan Hengtai Nutrition Co., Ltd. | 3rd party-Haccp doc - Prinova.pdf | 8/13/2024 | 8/13/2027 |
Gluten | CHENGDA PHARMACEUTICALS CO LTD | Allergen - 2024-06-18T133021.477.pdf | 5/30/2023 | 5/29/2025 |
Gluten | Kaiyuan Hengtai Nutrition Co., Ltd. | Allergen - 2025-01-24T085144.749.pdf | 8/8/2024 | 8/8/2026 |
Allergens | Northeast Pharmaceutical Group Co., Ltd. No.29 | Allergens.pdf | 7/31/2023 | 7/30/2025 |
Allergens | Kaiyuan Hengtai Nutrition Co., Ltd. | Allergens.pdf | 3/18/2024 | 3/18/2026 |
Allergens | CHENGDA PHARMACEUTICALS CO LTD | Allergens.pdf | 8/19/2024 | 8/19/2026 |
CoA Sample | Kaiyuan Hengtai Nutrition Co., Ltd. | Approved COA Template - 2024-06-18T160123.781.pdf | 10/29/2022 | 10/28/2024 |
CoA Sample | CHENGDA PHARMACEUTICALS CO LTD | Approved COA Template 58.pdf | 7/15/2020 | 7/15/2022 |
CoA Sample | Northeast Pharmaceutical Group Co., Ltd. No.29 | Approved COA Template 91.pdf | 5/25/2021 | 5/25/2023 |
WADA/NSF/NFL Statement | CHENGDA PHARMACEUTICALS CO LTD | Banned Substance (3).pdf | 7/12/2024 | 7/12/2026 |
Residual Statement | Kaiyuan Hengtai Nutrition Co., Ltd. | Contaminants and Impurities - 2024-01-31T123144.375.pdf | 1/27/2024 | 1/26/2025 |
Residual Statement | CHENGDA PHARMACEUTICALS CO LTD | Contaminants and Impurities - 2024-06-18T133842.979.pdf | 5/30/2024 | 5/30/2025 |
Heavy Metal | CHENGDA PHARMACEUTICALS CO LTD | Contaminants and Impurities - 2024-11-20T143933.883.pdf | 5/30/2023 | 5/29/2025 |
Heavy Metal | Kaiyuan Hengtai Nutrition Co., Ltd. | Contaminants and Impurities - 2025-01-24T090204.385.pdf | 8/9/2024 | 8/9/2026 |
Pesticide | Kaiyuan Hengtai Nutrition Co., Ltd. | Contaminants and Impurities - 2025-01-24T090204.385.pdf | 8/9/2024 | 8/9/2026 |
Country of Origin | Northeast Pharmaceutical Group Co., Ltd. No.37 | Country of Origin.pdf | 3/26/2019 | 3/25/2022 |
Country of Origin | Northeast Pharmaceutical Group Co., Ltd. No.29 | Country of Origin.pdf | 1/17/2024 | 1/16/2027 |
Country of Origin | Kaiyuan Hengtai Nutrition Co., Ltd. | Country of Origin.pdf | 6/6/2024 | 6/6/2027 |
Country of Origin | CHENGDA PHARMACEUTICALS CO LTD | Country of Origin.pdf | 6/18/2024 | 6/18/2027 |
GRAS/NDI/ODI Statement | Kaiyuan Hengtai Nutrition Co., Ltd. | FDA Regulatory Status L-Carnitine.pdf | 10/20/2023 | 10/19/2026 |
HACCP Process Flow Diagram | CHENGDA PHARMACEUTICALS CO LTD | Flow Chart - 2024-06-14T132840.593.pdf | 4/12/2023 | 4/11/2025 |
HACCP Process Flow Diagram | Kaiyuan Hengtai Nutrition Co., Ltd. | Flow Chart - 2024-11-06T141836.245.pdf | 8/9/2024 | 8/9/2026 |
FSVP Assessment Form | CHENGDA PHARMACEUTICALS CO LTD | FSVP Assessment Form.pdf | 1/8/2024 | 1/7/2025 |
FSVP Assessment Form | Kaiyuan Hengtai Nutrition Co., Ltd. | FSVP Assessment Form.pdf | 2/15/2025 | 2/15/2026 |
GMO | CHENGDA PHARMACEUTICALS CO LTD | GMO - 2024-06-18T132914.478.pdf | 5/29/2023 | 5/28/2025 |
GMO | Kaiyuan Hengtai Nutrition Co., Ltd. | GMO - 2025-01-24T090848.964.pdf | 8/9/2024 | 8/9/2026 |
Halal | CHENGDA PHARMACEUTICALS CO LTD | Halal Certificate - 2024-06-12T104401.248.pdf | 11/30/2022 | 11/26/2026 |
Halal | Kaiyuan Hengtai Nutrition Co., Ltd. | Halal Certificate - 2024-08-12T140917.115.pdf | 10/19/2022 | 10/18/2026 |
Ingredient Statement | Kaiyuan Hengtai Nutrition Co., Ltd. | Ingredient Breakdown_Declaration - 2024-01-31T123356.790.pdf | 1/27/2024 | 1/26/2025 |
Ingredient Statement | CHENGDA PHARMACEUTICALS CO LTD | Ingredient Breakdown_Declaration - 2024-09-16T124900.598.pdf | 11/22/2021 | 11/21/2024 |
Item Questionnaire | CHENGDA PHARMACEUTICALS CO LTD | Item Questionnaire.pdf | 4/5/2022 | 4/4/2025 |
Item Questionnaire | Kaiyuan Hengtai Nutrition Co., Ltd. | Item Questionnaire.pdf | 6/8/2022 | 6/7/2025 |
Kosher | CHENGDA PHARMACEUTICALS CO LTD | Kosher Certificate - 2024-09-18T113131.965.pdf | 7/5/2024 | 7/31/2025 |
Kosher | Northeast Pharmaceutical Group Co., Ltd. No.29 | Kosher Certificate - 2024-10-21T100250.580.pdf | 9/12/2024 | 9/30/2025 |
Kosher | Kaiyuan Hengtai Nutrition Co., Ltd. | Kosher Certificate - 2025-01-23T130903.197.pdf | 12/17/2024 | 12/31/2025 |
Safety Data Sheet (SDS) | Northeast Pharmaceutical Group Co., Ltd. No.29 | L-carnitine - NEPG - SDS.pdf | 4/27/2023 | 4/26/2025 |
WADA/NSF/NFL Statement | Kaiyuan Hengtai Nutrition Co., Ltd. | L-Carnitine ex Kaiyuan Hengtai - WADA_Banned Substance.pdf | 8/9/2024 | 8/9/2026 |
Shelf Life | Kaiyuan Hengtai Nutrition Co., Ltd. | l-Carnitine Kaiyuan Hengtai Nutrition 1 1.pdf | 12/2/2020 | 12/2/2022 |
National Bioengineered Food Disclosure Standard (Simplified) | Kaiyuan Hengtai Nutrition Co., Ltd. | National Bioengineered Food Disclosure Standard (Simplified).pdf | 5/6/2021 | 5/5/2024 |
California Prop. 65 | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_CaliforniaProp65.pdf | 12/31/2024 | 12/31/2026 |
California Prop. 65 | CHENGDA PHARMACEUTICALS CO LTD | NotApplicable_CaliforniaProp65.pdf | 12/31/2024 | 12/31/2026 |
FSVP Assessment Form | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_FSVPAssessmentForm.pdf | 12/31/2024 | 12/31/2025 |
Gluten | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_Gluten.pdf | 12/31/2024 | 12/31/2026 |
GMO | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_GMO.pdf | 12/31/2024 | 12/31/2026 |
HACCP Process Flow Diagram | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_HACCPProcessFlowDiagram.pdf | 12/31/2024 | 12/31/2026 |
Irradiation Status Statement | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_IrradiationStatusStatement.pdf | 12/31/2024 | 12/31/2026 |
Irradiation Status Statement | CHENGDA PHARMACEUTICALS CO LTD | NotApplicable_IrradiationStatusStatement.pdf | 12/31/2024 | 12/31/2026 |
Item Questionnaire | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_ItemQuestionnaire.pdf | 12/31/2024 | 12/31/2027 |
Nutrition | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_Nutrition.pdf | 12/31/2024 | 12/31/2027 |
Nutrition | CHENGDA PHARMACEUTICALS CO LTD | NotApplicable_Nutrition.pdf | 12/31/2024 | 12/31/2027 |
Product Specification Sheet | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_ProductSpecificationSheet.pdf | 12/31/2024 | 12/31/2027 |
Product Specification Sheet | CHENGDA PHARMACEUTICALS CO LTD | NotApplicable_ProductSpecificationSheet.pdf | 12/31/2024 | 12/31/2027 |
Sewage Statement | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_SewageStatement.pdf | 12/31/2024 | 12/31/2026 |
Sewage Statement | CHENGDA PHARMACEUTICALS CO LTD | NotApplicable_SewageStatement.pdf | 12/31/2024 | 12/31/2026 |
WADA/NSF/NFL Statement | Northeast Pharmaceutical Group Co., Ltd. No.29 | NotApplicable_WADANSFNFLStatement.pdf | 12/31/2024 | 12/31/2026 |
Nutrition | Kaiyuan Hengtai Nutrition Co., Ltd. | Nutrition.pdf | 5/13/2024 | 5/13/2027 |
Lot Code | Kaiyuan Hengtai Nutrition Co., Ltd. | Packaging Declaration - 2025-01-24T091939.176.pdf | 8/9/2025 | 8/8/2028 |
California Prop. 65 | Kaiyuan Hengtai Nutrition Co., Ltd. | Product Data Sheet - 2025-02-03T113406.949.pdf | 8/8/2024 | 8/8/2026 |
Shelf Life | CHENGDA PHARMACEUTICALS CO LTD | Product Data Sheet 2.pdf | 6/20/2019 | 6/19/2021 |
Irradiation Status Statement | Kaiyuan Hengtai Nutrition Co., Ltd. | Production Process (87).pdf | 8/9/2024 | 8/9/2026 |
Heavy Metal | Northeast Pharmaceutical Group Co., Ltd. No.29 | RE_ Continuing supplier approval questionnaire - Northeast Pharmaceutical 6 1.pdf | 9/30/2020 | 9/30/2022 |
Vegan/Vegetarian Statement | Kaiyuan Hengtai Nutrition Co., Ltd. | Regulatory Information Sheet - 2023-11-03T133716.777.pdf | 10/29/2022 | 10/28/2024 |
GRAS/NDI/ODI Statement | CHENGDA PHARMACEUTICALS CO LTD | Regulatory Information Sheet - 2024-06-14T133135.312.pdf | 4/12/2022 | 4/11/2025 |
Vegan/Vegetarian Statement | CHENGDA PHARMACEUTICALS CO LTD | Regulatory Information Sheet - 2024-11-20T143212.476.pdf | 4/12/2023 | 4/11/2025 |
Safety Data Sheet (SDS) | Kaiyuan Hengtai Nutrition Co., Ltd. | SDS - 2025-01-24T091028.243.pdf | 1/8/2024 | 1/7/2027 |
Safety Data Sheet (SDS) | CHENGDA PHARMACEUTICALS CO LTD | SDS 20.pdf | 5/30/2022 | 5/29/2025 |
Label Sample | Kaiyuan Hengtai Nutrition Co., Ltd. | shipping mark-LC_Kaiyuan Hengtai Nut.pdf | 3/18/2021 | 3/18/2022 |
Suitability Requirements | Kaiyuan Hengtai Nutrition Co., Ltd. | Suitability Requirements.pdf | 11/2/2022 | 11/1/2025 |
Suitability Requirements | CHENGDA PHARMACEUTICALS CO LTD | Suitability Requirements.pdf | 6/18/2024 | 6/18/2027 |
Product Specification Sheet | Kaiyuan Hengtai Nutrition Co., Ltd. | US SPECIFICATION - 2024-07-29T162548.539.pdf | 3/17/2022 | 3/16/2025 |